View More Recent Stories

Apr 10, 2022 06:46PM Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab
Apr 4, 2022 08:30AM Commercial Launch: Illuccix® Now Available to Order in the United States
Mar 30, 2022 07:09PM Change of Composition of the Telix Board of Directors
Mar 29, 2022 07:00AM New Video Series "PSMA PET/CT TODAY" Discusses the Future of Prostate Cancer Care with Leading Experts
Mar 28, 2022 10:29PM Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment
Mar 22, 2022 09:47PM Telix Advances Development of Glioblastoma Therapy Program
Mar 21, 2022 06:41PM Telix Radiopharmaceutical Production Facility Buildout Commences
Mar 7, 2022 05:37PM ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment
Feb 10, 2022 04:09PM Telix and SHINE partner for Lutetium-177 Supply
Feb 8, 2022 05:27PM Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement
Jan 26, 2022 04:51PM First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
Dec 21, 2021 07:49PM Telix Collaborates with Olivia Newton-John Cancer Research Institute on Brain Cancer Imaging Study
Dec 19, 2021 04:47PM FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®
Nov 30, 2021 04:45PM Illuccix® Granted Use Authorisation for Prostate Cancer Imaging in Brazil
Nov 1, 2021 07:25PM Australian TGA Approves Illuccix® for Prostate Cancer Imaging
Oct 19, 2021 06:12PM IPAX-1 Late Breaking Oral Presentation at the Congress of Neurological Surgeons (CNS) Meeting
Oct 18, 2021 01:21AM First Cyclotron Removed from Seneffe Production Facility by SCK CEN
Oct 4, 2021 05:34PM First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
Sep 20, 2021 08:31PM Second Industry Body Updates Guidance for Use of PSMA PET Imaging
Sep 13, 2021 08:36PM NCCN Guidelines Updated to Include PSMA-PET Imaging
Sep 13, 2021 06:41PM FDA Approves Phase II Kidney Cancer Therapy Study
Sep 9, 2021 01:34AM Telix In-Licences Novel Tumour Microenvironment PET Tracer
Sep 7, 2021 08:00AM Telix to Collaborate With Kettering Health on Diagnostic PSMA Imaging & Targeting Theranostics
Aug 31, 2021 07:12AM Michael Didocha Joins Telix as Chief Financial Officer, Americas
Aug 23, 2021 02:00AM Lightpoint Medical and Telix Pharmaceuticals Announce Strategic Collaboration Agreement
Aug 18, 2021 06:47PM Telix Expands Prostate Cancer Activity with GenesisCare Collaboration
Aug 17, 2021 09:26PM Two New Studies to Explore Telix Assets in Breast Cancer Theranostics
Aug 17, 2021 09:02PM Telix and Merck KGaA, Darmstadt, Germany, to Commence Pan-Cancer Clinical Combination Studies
Aug 16, 2021 07:55PM Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia
Aug 4, 2021 06:30PM First Patient Dosed in CUPID Study of Telix’s Targeted Alpha Therapy Candidate for Prostate Cancer
Jun 22, 2021 07:22PM First Patient Dosed in Clinical Study of TLX250-CDx in Bladder Cancer
Jun 14, 2021 08:00AM Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education Platform Focused on Radiopharmaceutical Research
Jun 11, 2021 08:04AM Telix Launches “Gallium Wave” Awareness Website
Jun 1, 2021 08:00AM Telix to Present at the 2021 Jefferies Virtual Healthcare Conference
May 27, 2021 08:00AM Cardinal Health and Telix Launch Gallium Awareness Campaign With Release of White-Paper: “Moving Beyond the Myth”
May 24, 2021 08:58PM TLX66 Meets Study Objectives in Patients with AL Amyloidosis
May 9, 2021 07:13PM Telix Commences Phase III Clinical Trial of Prostate Cancer Therapy
Mar 30, 2021 06:02PM Telix Pharmaceuticals and Grand River Aseptic Manufacturing Complete Agreement for Commercial Manufacturing of Illuccix®
Mar 18, 2021 03:00AM ITM Enters Global Supply Agreements with Telix Pharmaceuticals for Clinical and Commercial Use of ITM’s n.c.a. Lutetium-177
Jan 24, 2021 05:54PM First US Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product
Jan 12, 2021 08:00AM ARTMS and Telix Pharmaceuticals Announce Successful Production of PSMA-11 with Cyclotron Produced ⁶⁸Ga from a Solid Target
Sep 2, 2020 08:00PM Telix Pharmaceuticals Enters Strategic Collaboration with Varian Medical Systems for Advanced Prostate Imaging
Jul 25, 2019 01:30PM Portland Investment Counsel Inc. Leads Investment in Telix Pharmaceuticals Limited via Private Placement
View More Recent Stories